SD BIOSENSOR, INC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,210 KRW | -0.75% |
|
-2.95% | -19.49% |
ETFs positioned on SD BioSensor, Inc
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.09% | 1 M€ | +3.49% | - | |
| 0.09% | 3 M€ | -.--% | - | |
| 0.05% | 11 M€ | +10.06% | ||
| 0.02% | 15 M€ | +24.53% | ||
| 0.02% | 2 M€ | -.--% | ||
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +7.14% | - | |
| 0.00% | 114 M€ | +9.37% | - | |
| 0.00% | 36 M€ | +11.80% | - | |
| 0.00% | 324 M€ | +9.48% | - | |
| 0.00% | 40 M€ | +7.94% | - |
SD Biosensor Inc is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.49% | 815M | |
| -6.51% | 12.28B | |
| +98.69% | 8.54B | |
| -22.31% | 6.58B | |
| +6.16% | 5.77B | |
| -23.61% | 3.48B | |
| +5.84% | 2.54B | |
| +39.18% | 2.41B | |
| -8.37% | 2.3B | |
| -69.05% | 2.07B |
- Stock Market
- Equities
- A137310 Stock
- ETFs SD BioSensor, Inc
